AP1246A - Substituted pyrazoles as p38 Kinase inhibitors. - Google Patents

Substituted pyrazoles as p38 Kinase inhibitors.

Info

Publication number: AP1246A
Authority: AP; ARIPO
Prior art keywords: kinase inhibitors; substituted pyrazoles; pyrazoles; substituted; class
Prior art date: 1997-05-22

Application number

APAP/P/1999/001715A

Other languages

English (en)

Other versions

AP9901715A0 (en

Inventor

Ashok Anantanarayan

Michael Clare

Paul W Collins

Joyce Zuowu Crich

Rajesh Devraj

Daniel L Flynn

Lifeng Geng

Gunnar J Hanson

Francis J Koszyk

Shuyuan Liao

Richard A Partis

Shashidhar N Rao

Shaun Raj Selness

Michael J South

Michael A Stealey

Richard M Weier

Xiangdong Xu

Original Assignee

Searle & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-22

Filing date

1998-05-22

Publication date

2004-02-07

1998-05-22 Application filed by Searle & Co filed Critical Searle & Co

1999-12-31 Publication of AP9901715A0 publication Critical patent/AP9901715A0/xx

2004-02-07 Application granted granted Critical

2004-02-07 Publication of AP1246A publication Critical patent/AP1246A/en

Links

150000003217 pyrazoles Chemical class 0.000 title abstract 2
229940043355 kinase inhibitor Drugs 0.000 title 1
239000003757 phosphotransferase inhibitor Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Rheumatology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Pulmonology (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Obesity (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Endocrinology (AREA)
Vascular Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Transplantation (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

APAP/P/1999/001715A 1997-05-22 1998-05-22 Substituted pyrazoles as p38 Kinase inhibitors. AP1246A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4757097P	1997-05-22	1997-05-22
PCT/US1998/010436 WO1998052940A1 (en)	1997-05-22	1998-05-22	SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS

Publications (2)

Publication Number	Publication Date
AP9901715A0 AP9901715A0 (en)	1999-12-31
AP1246A true AP1246A (en)	2004-02-07

Family

ID=21949743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
APAP/P/1999/001715A AP1246A (en)	1997-05-22	1998-05-22	Substituted pyrazoles as p38 Kinase inhibitors.

Country Status (24)

Country	Link
EP (1)	EP1000055A1 (is)
JP (1)	JP2002508754A (is)
KR (1)	KR20010012854A (is)
CN (1)	CN1264377A (is)
AP (1)	AP1246A (is)
AU (1)	AU754830C (is)
BG (1)	BG64313B1 (is)
BR (1)	BR9809147A (is)
CA (1)	CA2291115A1 (is)
EA (1)	EA003925B1 (is)
EE (1)	EE9900527A (is)
GE (1)	GEP20033053B (is)
HU (1)	HUP0001880A3 (is)
ID (1)	ID22982A (is)
IL (1)	IL132991A (is)
IS (1)	IS5257A (is)
NO (1)	NO995695L (is)
NZ (1)	NZ501112A (is)
OA (1)	OA12981A (is)
PL (1)	PL337020A1 (is)
SK (1)	SK157899A3 (is)
TR (1)	TR200000235T2 (is)
WO (1)	WO1998052940A1 (is)
ZA (1)	ZA984358B (is)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW289752B (is) *	1994-03-11	1996-11-01	Ciba Geigy Ag
US5559137A (en) *	1994-05-16	1996-09-24	Smithkline Beecham Corp.	Compounds
US6979686B1 (en)	2001-12-07	2005-12-27	Pharmacia Corporation	Substituted pyrazoles as p38 kinase inhibitors
US6514977B1 (en) *	1997-05-22	2003-02-04	G.D. Searle & Company	Substituted pyrazoles as p38 kinase inhibitors
EP1019394A1 (en)	1997-05-22	2000-07-19	G.D. Searle & Co.	PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
AU7966198A (en)	1997-06-13	1998-12-30	Smithkline Beecham Corporation	Novel pyrazole and pyrazoline substituted compounds
US7301021B2 (en)	1997-07-02	2007-11-27	Smithkline Beecham Corporation	Substituted imidazole compounds
US6858617B2 (en)	1998-05-26	2005-02-22	Smithkline Beecham Corporation	Substituted imidazole compounds
US6184226B1 (en) *	1998-08-28	2001-02-06	Scios Inc.	Quinazoline derivatives as inhibitors of P-38 α
US6649617B1 (en)	1998-10-07	2003-11-18	Smithkline Beecham Corporation	Treatment for stroke management
DE69914357T2 (de)	1998-11-04	2004-11-11	Smithkline Beecham Corp.	Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
CA2355075C (en)	1998-12-16	2009-12-08	Aventis Pharma Limited	Heteroaryl-cyclic acetals
US6191147B1 (en) *	1998-12-24	2001-02-20	Ppd Discovery, Inc.	Pyrazole compounds and uses thereof
KR100711538B1 (ko) *	1998-12-25	2007-04-27	아스카 세이야쿠 가부시키가이샤	아미노피라졸 유도체
TW502019B (en)	1999-03-26	2002-09-11	Cocensys Inc	Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
DE60020560T2 (de)	1999-06-03	2006-04-27	Teikoku Hormone Mfg. Co., Ltd.	Substituierte pyrazol-derivate
US7122666B2 (en)	1999-07-21	2006-10-17	Sankyo Company, Limited	Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
BR0013551A (pt) *	1999-08-13	2003-06-17	Vertex Pharma	Inibidores de cinases n-terminal cjun (jnk) e outras cinases de proteìnas
AU7922100A (en) *	1999-10-25	2001-05-08	Basf Aktiengesellschaft	Agrochemical compositions containing pyrazoles as the active agents and use of said compositions as plant protection agents with a fungicidal action
DE19952147A1 (de)	1999-10-29	2001-05-03	Boehringer Ingelheim Pharma	Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
EP1233950B1 (en)	1999-11-23	2005-10-05	Smithkline Beecham Corporation	3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS
ATE281439T1 (de)	1999-11-23	2004-11-15	Smithkline Beecham Corp	3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
JP2003514900A (ja)	1999-11-23	2003-04-22	スミスクライン・ビーチャム・コーポレイション	ＣＳＢＰ／ｐ３８キナーゼ阻害剤としての３，４−ジヒドロ−（１Ｈ）−キナゾリン−２−オン化合物
US7235551B2 (en)	2000-03-02	2007-06-26	Smithkline Beecham Corporation	1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
HK1052705B (en)	2000-08-14	2006-09-29	Ortho-Mcneil Pharmaceutical, Inc.	Substituted pyrazole
US7199124B2 (en)	2001-02-02	2007-04-03	Takeda Pharmaceutical Company Limited	JNK inhibitor
GB0102687D0 (en)	2001-02-02	2001-03-21	Pharmacia & Upjohn Spa	Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
US7074801B1 (en)	2001-04-26	2006-07-11	Eisai Co., Ltd.	Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
SK287857B6 (sk)	2001-05-24	2012-01-04	Eli Lilly And Company	Novel pyrrole derivatives as pharmaceutical agents
AU2002330096B2 (en)	2001-09-25	2007-11-08	Pharmacia Corporation	Process for making substituted pyrazoles
RU2277534C2 (ru) *	2001-09-25	2006-06-10	Фармация Корпорейшн	Способ получения замещенных пиразолов
US7057049B2 (en)	2001-09-25	2006-06-06	Pharmacia Corporation	Process for making substituted pyrazoles
TW200400960A (en) *	2002-06-05	2004-01-16	Pharmacia Corp	Novel pyrazoles and their use as P38 kinase inhibitors
ES2278170T3 (es)	2002-07-09	2007-08-01	BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG	Composiciones farmaceuticas de anticolinergicos e inhibidores de la quinasa p38 en el tratamiento de enfermedades respiratorias.
GB0215844D0 (en)	2002-07-09	2002-08-14	Novartis Ag	Organic compounds
GB0217786D0 (en) *	2002-07-31	2002-09-11	Glaxo Group Ltd	Compounds
AU2003265395A1 (en)	2002-08-14	2004-03-03	Ppd Discovery, Inc.	Prenylation inhibitors and methods of their synthesis and use
US6649638B1 (en)	2002-08-14	2003-11-18	Ppd Discovery, Inc.	Prenylation inhibitors and methods of their synthesis and use
WO2004026302A1 (en) *	2002-09-19	2004-04-01	Eli Lilly And Company	Methods of inhibiting tgf beta with substituted pyrazoles
GB0229618D0 (en)	2002-12-19	2003-01-22	Cancer Rec Tech Ltd	Pyrazole compounds
US7622471B2 (en)	2003-02-07	2009-11-24	Daiichi Pharmaceutical Co., Ltd.	Pyrazole derivatives having a pyridazine and pyridine functionality
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
EA012119B1 (ru)	2004-08-12	2009-08-28	Пфайзер Инк.	ПРОИЗВОДНЫЕ ТРИАЗОЛОПИРИДИНСУЛЬФАНИЛА В КАЧЕСТВЕ ИНГИБИТОРОВ p38 MAP КИНАЗЫ
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
US7939536B2 (en)	2004-12-28	2011-05-10	Aska Pharmaceutical Co., Ltd.	Pyrimidinylisoxazole derivatives
WO2007105058A2 (en) *	2006-03-16	2007-09-20	Pfizer Products Inc.	Pyrazole compounds
EP2036905B1 (en)	2006-06-28	2012-12-12	ASKA Pharmaceutical Co., Ltd.	Pyridylisoxazole derivative
WO2008001929A1 (en)	2006-06-28	2008-01-03	Aska Pharmaceutical Co., Ltd.	Treatment agent for inflammatory bowel disease
AU2008215659B2 (en)	2007-02-16	2012-11-01	Aska Pharmaceutical Co., Ltd.	Pharmaceutical composition comprising microparticle oily suspension
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
JP2010533147A (ja) *	2007-07-13	2010-10-21	アデックスファルマエス．エイ．	代謝調節型グルタミン酸レセプターのモジュレーターとしてのピラゾール誘導体
TW200927115A (en)	2007-11-16	2009-07-01	Boehringer Ingelheim Int	Aryl-and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
CL2009000904A1 (es) *	2008-04-21	2010-04-30	Shionogi & Co	Compuestos derivados de ciclohexil sulfonamidas que tienen actividad antagonista en el receptor npy y5, composicion farmaceutica y formulacion farmaceutica que los comprende.
AR071719A1 (es)	2008-05-13	2010-07-07	Boehringer Ingelheim Int	Derivados aliciclicos de acido carboxilico de benzomorfanos y estructuras relacionadas, medicamentos que contienen dichos compuestos y su uso.procesos de obtencion
PT2324008E (pt)	2008-07-24	2012-06-25	Nerviano Medical Sciences Srl	3,4-diarilpirazoles como inibidores da proteína quinase
CA2735204C (en) *	2008-08-25	2017-06-20	Boehringer Ingelheim International Gmbh	Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use
CN102177138A (zh) *	2008-10-23	2011-09-07	隆萨有限公司	合成取代的吡唑类的方法
MX2011005221A (es) *	2008-11-21	2011-08-03	Raqualia Pharma Inc	Nuevo derivado de la pirazol-3-carboxamida que tiene actividad de antagonista del receptor de 5-ht2b.
US8703765B2 (en)	2009-06-02	2014-04-22	Boehringer Ingelheim International Gmbh	Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
US8927539B2 (en)	2009-06-11	2015-01-06	Vitae Pharmaceuticals, Inc.	Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
IN2012DN01693A (is) *	2009-08-26	2015-06-05	Novartis Ag
AR077975A1 (es)	2009-08-28	2011-10-05	Irm Llc	Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina
EP2308866A1 (de)	2009-10-09	2011-04-13	Bayer CropScience AG	Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
CN102762551A (zh)	2009-12-21	2012-10-31	拜尔农作物科学股份公司	噻吩基吡(嘧)啶基吡唑及其用于防治植物致病菌的用途
CN104958294A (zh)	2010-01-27	2015-10-07	内尔维安诺医学科学有限公司	作为蛋白激酶抑制剂的3,4-二芳基吡唑的亚磺酰氨基衍生物
AR081810A1 (es)	2010-04-07	2012-10-24	Bayer Cropscience Ag	Piridinilpirazoles biciclicos
WO2011159760A1 (en)	2010-06-16	2011-12-22	Vitae Pharmaceuticals, Inc.	Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
EP2601185B1 (en)	2010-08-03	2015-10-07	Nerviano Medical Sciences S.r.l.	Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents
CA2819961C (en) *	2010-12-20	2015-08-18	Pfizer Inc.	Novel fused pyridine compounds as casein kinase inhibitors
AR086992A1 (es)	2011-06-20	2014-02-05	Bayer Ip Gmbh	Tienilpiri(mi)dinilpirazoles
WO2013025664A1 (en)	2011-08-17	2013-02-21	Boehringer Ingelheim International Gmbh	Indenopyridine derivatives
MX355016B (es)	2011-10-06	2018-04-02	Bayer Ip Gmbh	Heterociclilpiri(mi)dinilpirazoles como fungicidas.
JP6211522B2 (ja)	2011-10-06	2017-10-11	バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＧｍｂＨ	ヘテロシクリルピリ（ミ）ジニルピラゾール
DE102011115525A1 (de)	2011-10-11	2013-04-11	Boehringer Ingelheim International Gmbh	Zweiteilige Flasche mit einem darin angeordneten Trockenmittel
RU2622015C2 (ru)	2011-11-11	2017-06-08	Новартис Аг	Способ лечения пролиферативного заболевания
SI2782557T1 (sl)	2011-11-23	2019-02-28	Array Biopharma, Inc.,	Farmacevtske formulacije
HK1224172A1 (zh)	2013-03-15	2017-08-18	加州生物医学研究所	用於诱导软骨形成的化合物和方法
US9573904B2 (en) *	2013-12-12	2017-02-21	Sumitomo Chemical Company, Limited	Aromatic compound and use thereof
CN104829536B (zh) *	2015-05-04	2017-12-29	陕西科技大学	一种具抗肿瘤活性的苯基吡唑羧酸类化合物及其合成方法
JP6746614B2 (ja) *	2015-05-27	2020-08-26	杏林製薬株式会社	ウレア誘導体、またはその薬理学的に許容される塩
CN112480079B (zh) *	2017-11-08	2022-03-11	北京嘉林药业股份有限公司	化合物及其治疗癌症的用途
CA3121202A1 (en)	2018-11-30	2020-06-04	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof
WO2020124397A1 (en)	2018-12-19	2020-06-25	Inventisbio Shanghai Ltd.	C-terminal src kinase inhibitors
US12479816B2 (en)	2019-02-08	2025-11-25	University of Pittsburgh—of the Commonwealth System of Higher Education	20-HETE formation inhibitors
CN115210229A (zh)	2020-01-03	2022-10-18	博格有限责任公司	多环酰胺作为治疗癌症的ube2k调节剂
EP3978487A1 (en) *	2020-09-30	2022-04-06	Origo Biopharma, S.L.	2-(3-pyridin-2-yl-4-quinolin-4-yl-pyrazol-1-yl)-acetamide derivatives as inhibitors of transforming growth factor-beta receptor i/alk5
JP2024503280A (ja) *	2020-12-29	2024-01-25	レボリューションメディシンズインコーポレイテッド	Ｓｏｓ１阻害剤及びその使用
WO2025231152A1 (en) *	2024-04-30	2025-11-06	The Cleveland Clinic Foundation	Compounds and methods for restoring beta-adrenergic receptor function

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996003385A1 (en) *	1994-07-21	1996-02-08	G.D. Searle & Co.	3,4-substituted pyrazoles for the treatment of inflammation
US5559137A (en) *	1994-05-16	1996-09-24	Smithkline Beecham Corp.	Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2753659B2 (ja) *	1990-09-03	1998-05-20	株式会社大塚製薬工場	ピラゾール誘導体
US5593992A (en) *	1993-07-16	1997-01-14	Smithkline Beecham Corporation	Compounds
JP3734180B2 (ja) *	1994-12-28	2006-01-11	エーザイ株式会社	新規ピラゾール誘導体

1998
- 1998-05-22 AU AU75883/98A patent/AU754830C/en not_active Ceased
- 1998-05-22 KR KR19997010820A patent/KR20010012854A/ko not_active Ceased
- 1998-05-22 CA CA002291115A patent/CA2291115A1/en not_active Abandoned
- 1998-05-22 EE EEP199900527A patent/EE9900527A/xx unknown
- 1998-05-22 EP EP98923642A patent/EP1000055A1/en not_active Withdrawn
- 1998-05-22 GE GEAP19985095A patent/GEP20033053B/en unknown
- 1998-05-22 SK SK1578-99A patent/SK157899A3/sk unknown
- 1998-05-22 IL IL13299198A patent/IL132991A/xx not_active IP Right Cessation
- 1998-05-22 JP JP55065098A patent/JP2002508754A/ja not_active Withdrawn
- 1998-05-22 BR BR9809147-6A patent/BR9809147A/pt not_active Application Discontinuation
- 1998-05-22 EA EA199900953A patent/EA003925B1/ru not_active IP Right Cessation
- 1998-05-22 NZ NZ501112A patent/NZ501112A/xx unknown
- 1998-05-22 ID IDW991425A patent/ID22982A/id unknown
- 1998-05-22 AP APAP/P/1999/001715A patent/AP1246A/en active
- 1998-05-22 TR TR2000/00235T patent/TR200000235T2/xx unknown
- 1998-05-22 ZA ZA984358A patent/ZA984358B/xx unknown
- 1998-05-22 HU HU0001880A patent/HUP0001880A3/hu unknown
- 1998-05-22 WO PCT/US1998/010436 patent/WO1998052940A1/en not_active Ceased
- 1998-05-22 CN CN98807369A patent/CN1264377A/zh active Pending
- 1998-05-22 PL PL98337020A patent/PL337020A1/xx unknown
1999
- 1999-11-19 IS IS5257A patent/IS5257A/is unknown
- 1999-11-19 NO NO995695A patent/NO995695L/no not_active Application Discontinuation
- 1999-11-22 OA OA9900252A patent/OA12981A/en unknown
- 1999-12-08 BG BG103964A patent/BG64313B1/bg unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5559137A (en) *	1994-05-16	1996-09-24	Smithkline Beecham Corp.	Compounds
WO1996003385A1 (en) *	1994-07-21	1996-02-08	G.D. Searle & Co.	3,4-substituted pyrazoles for the treatment of inflammation

Also Published As

Publication number	Publication date
BG64313B1 (bg)	2004-09-30
JP2002508754A (ja)	2002-03-19
SK157899A3 (en)	2000-08-14
NO995695D0 (no)	1999-11-19
IS5257A (is)	1999-11-19
CN1264377A (zh)	2000-08-23
NO995695L (no)	2000-01-21
IL132991A0 (en)	2001-03-19
ID22982A (id)	1999-12-23
EA199900953A1 (ru)	2000-10-30
CA2291115A1 (en)	1998-11-26
AU754830B2 (en)	2002-11-28
KR20010012854A (ko)	2001-02-26
ZA984358B (en)	1999-05-24
EP1000055A1 (en)	2000-05-17
EA003925B1 (ru)	2003-10-30
EE9900527A (et)	2000-06-15
HUP0001880A2 (en)	2001-03-28
AP9901715A0 (en)	1999-12-31
BG103964A (en)	2000-08-31
NZ501112A (en)	2002-10-25
GEP20033053B (en)	2003-08-25
IL132991A (en)	2005-11-20
OA12981A (en)	2006-10-13
PL337020A1 (en)	2000-07-31
WO1998052940A1 (en)	1998-11-26
AU7588398A (en)	1998-12-11
HUP0001880A3 (en)	2002-03-28
TR200000235T2 (tr)	2000-05-22
AU754830C (en)	2004-02-12
BR9809147A (pt)	2000-08-01

Publication	Publication Date	Title
AP1246A (en)	2004-02-07	Substituted pyrazoles as p38 Kinase inhibitors.
AP2001002172A0 (en)	2001-06-30	Substituted pyrazoles as p38 kinase inhibitors
BR9809451A (pt)	2000-06-20	Pirazóis substituìdos com 3(5)-heteroarila como inibidores de quinase p38.
AU3328499A (en)	1999-10-11	Phthalazinone pde iii/iv inhibitors
IL127877A (en)	2001-01-28	Pyrazole derivatives
NO942618L (no)	1994-08-30	Imidazolderivater og deres anvendelse som cytokin-inhibitorer
PL327735A1 (en)	1998-12-21	Novel substituted derivatives of imidazole
MXPA02011977A (es)	2003-04-22	Herbicidas de piridina sustituidas.
MY128485A (en)	2007-02-28	Pesticidal 1-arylpyrazoles
NZ544591A (en)	2009-07-31	Pyrrolodihydroisoquinolines as PDE10 inhibitors
DK0772603T3 (da)	2002-07-15	Substituerede pyrimidinforbindelser og deres anvendelse
ATE305787T1 (de)	2005-10-15	3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
AU1783201A (en)	2001-06-04	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
GB0308201D0 (en)	2003-05-14	Novel compounds
ATE291018T1 (de)	2005-04-15	Pyrazol verbindungen und ihre verwendung
PT920426E (pt)	2004-02-27	Novos derivados de tiazole com efeito inibidor de fosfodiesterase
AU1781601A (en)	2001-06-04	3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
AP2001002188A0 (en)	2001-06-30	5HT1 antagonists for antidepressant therapy.
MX9702203A (es)	1997-06-28	Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida.
ATE374189T1 (de)	2007-10-15	Phthalazinon-derivate als pde 4 hemmer
AU2001296699A1 (en)	2002-05-21	Condensed pyrazindione derivatives as pde inhibitors
MXPA03000887A (es)	2004-04-05	Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa.
MY141481A (en)	2010-04-30	Substituted pyrazoles as p38 kinase inhibitors
PL345966A1 (en)	2002-01-14	N-substituted azabicycloheptane derivatives, production and use thereof
SI0937075T1 (en)	2004-06-30	New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.